John Rogers

10.6k total citations · 2 hit papers
50 papers, 3.2k citations indexed

About

John Rogers is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, John Rogers has authored 50 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 15 papers in Pulmonary and Respiratory Medicine and 11 papers in Molecular Biology. Recurrent topics in John Rogers's work include Platelet Disorders and Treatments (9 papers), Hemophilia Treatment and Research (8 papers) and Lung Cancer Treatments and Mutations (7 papers). John Rogers is often cited by papers focused on Platelet Disorders and Treatments (9 papers), Hemophilia Treatment and Research (8 papers) and Lung Cancer Treatments and Mutations (7 papers). John Rogers collaborates with scholars based in United States, Guatemala and France. John Rogers's co-authors include Harvey J. Weiss, E. C. Gilmore, Leon W. Hoyer, André Varma, Frederick R. Rickles, William J. Vicic, Naresh C. Gupta, Joseph A. Fontana, Geoffrey M. Graeber and Alvin H. Moss and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

John Rogers

50 papers receiving 2.9k citations

Hit Papers

Quantitative Assay of a Plasma Factor Deficient in von Wi... 1958 2026 1980 2003 1973 1958 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Rogers United States 26 1.2k 643 386 339 323 50 3.2k
Masako Hara Japan 43 577 0.5× 545 0.8× 916 2.4× 281 0.8× 396 1.2× 183 5.1k
Nurit Rosenberg Israel 31 1.6k 1.3× 369 0.6× 720 1.9× 74 0.2× 431 1.3× 118 3.5k
David G. Savage United States 35 1.7k 1.4× 337 0.5× 1.0k 2.6× 71 0.2× 807 2.5× 114 6.4k
Antonio Ruggiero Italy 35 218 0.2× 583 0.9× 711 1.8× 134 0.4× 604 1.9× 248 4.1k
Henk Visser Netherlands 24 572 0.5× 235 0.4× 335 0.9× 388 1.1× 257 0.8× 90 3.0k
Akira Sakai Japan 32 505 0.4× 187 0.3× 906 2.3× 382 1.1× 314 1.0× 238 3.7k
Frederick W.K. Tam United Kingdom 34 575 0.5× 465 0.7× 642 1.7× 102 0.3× 512 1.6× 90 3.4k
Myron Pollycove United States 27 375 0.3× 452 0.7× 305 0.8× 668 2.0× 279 0.9× 82 2.1k
Cristina Battaglia Italy 38 214 0.2× 443 0.7× 1.8k 4.6× 78 0.2× 99 0.3× 112 4.2k
Leon G. Fine United States 46 219 0.2× 1.1k 1.6× 2.7k 7.1× 284 0.8× 165 0.5× 125 5.8k

Countries citing papers authored by John Rogers

Since Specialization
Citations

This map shows the geographic impact of John Rogers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Rogers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Rogers more than expected).

Fields of papers citing papers by John Rogers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Rogers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Rogers. The network helps show where John Rogers may publish in the future.

Co-authorship network of co-authors of John Rogers

This figure shows the co-authorship network connecting the top 25 collaborators of John Rogers. A scholar is included among the top collaborators of John Rogers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Rogers. John Rogers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caton, Barney P., et al.. (2021). Taxonomic, geographic, and diversity trends for exotic plant pests in recent biosurveillance articles. Journal of Pest Science. 95(2). 577–591. 2 indexed citations
2.
Chi, Alexander, Nam P. Nguyen, James S. Welsh, et al.. (2014). Strategies of Dose Escalation in the Treatment of Locally Advanced Non-Small Cell Lung Cancer: Image Guidance and Beyond. Frontiers in Oncology. 4. 156–156. 11 indexed citations
3.
Pillai, Rathi N., Joseph Aisner, Suzanne E. Dahlberg, et al.. (2014). Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501). Cancer Chemotherapy and Pharmacology. 74(1). 177–183. 21 indexed citations
5.
Edelman, Martin J., Wael A. Harb, Ralph V. Boccia, et al.. (2012). Multicenter Trial of EC145 in Advanced, Folate-Receptor Positive Adenocarcinoma of the Lung. Journal of Thoracic Oncology. 7(10). 1618–1621. 33 indexed citations
6.
Craig, Michael, et al.. (2008). Can Positron Emission Tomography Be Used as a Staging Tool for Small-Cell Lung Cancer?. Clinical Lung Cancer. 9(1). 30–34. 38 indexed citations
7.
Zhang, Peilin, et al.. (2004). CHK2 kinase expression is down-regulated due to promoter methylation in non-small cell lung cancer.. Molecular Cancer. 3(1). 14–14. 68 indexed citations
8.
Théberge, Jean, Robert Bartha, Dick Drost, et al.. (2002). Glutamate and Glutamine Measured With 4.0 T Proton MRS in Never-Treated Patients With Schizophrenia and Healthy Volunteers. American Journal of Psychiatry. 159(11). 1944–1946. 302 indexed citations
10.
Dowell, Jonathan E., et al.. (2001). A Phase II trial of 6-Hydroxymethylacylfulvene (MGI-114, Irofulven) in Patients with Advanced Non-Small Cell Cancer Previously Treated with Chemotherapy. Investigational New Drugs. 19(1). 85–88. 16 indexed citations
11.
Gupta, Naresh C., et al.. (2001). Clinical Utility of PET-FDG Imaging in Differentiation of Benign from Malignant Adrenal Masses in Lung Cancer. Clinical Lung Cancer. 3(1). 59–64. 55 indexed citations
12.
Gupta, Naresh C., et al.. (2000). Treatment Outcome of Lung Cancer Patients as Optimized by Preoperative Whole-Body Positron Emission Tomography Fluorodeoxyglucose Imaging. Clinical Lung Cancer. 2(2). 146–150. 4 indexed citations
13.
Gupta, Naresh C., Geoffrey M. Graeber, John Rogers, & Harry A. Bishop. (1999). Comparative Efficacy of Positron Emission Tomography with FDG and Computed Tomographic Scanning in Preoperative Staging of Non-Small Cell Lung Cancer. Annals of Surgery. 229(2). 286–291. 91 indexed citations
14.
Ponte, Charles D., Michael J. Lewis, & John Rogers. (1989). Heinz-Body Hemolytic Anemia Associated with Phenazopyridine and Sulfonamide. DICP. 23(2). 140–142. 2 indexed citations
15.
Rogers, John, et al.. (1989). Intracranial Granulocytic Sarcoma in Postpolycythemia Myeloid Metaplasia. Southern Medical Journal. 82(12). 1564–1567. 3 indexed citations
16.
Lempert, Kenneth D., John Rogers, & Margaret J. Albrink. (1988). Effects of Dietary Fish Oil on Serum Lipids and Blood Coagulation in Peritoneal Dialysis Patients. American Journal of Kidney Diseases. 11(2). 170–175. 21 indexed citations
17.
Rogers, John, Anthony J. Murgo, Joseph A. Fontana, & Peter C. Raich. (1988). Chemotherapy for breast cancer decreases plasma protein C and protein S.. Journal of Clinical Oncology. 6(2). 276–281. 121 indexed citations
18.
Mikhail, George R., Roushdy S. Boulos, Robert S. Knighton, et al.. (1986). Cranial Invasion by Basal Cell Carcinoma. The Journal of Dermatologic Surgery and Oncology. 12(5). 459–464. 11 indexed citations
19.
Hendrick, Alex, et al.. (1979). Ocular complications following blast transformation in chronic myelogenous leukemia. American Journal of Hematology. 7(4). 389–394. 5 indexed citations
20.
Magilligan, Donald J., John Rogers, Robert S. Knighton, & Julio C. Dávila. (1976). Pulmonary neoplasm with solitary cerebral metastasis. Journal of Thoracic and Cardiovascular Surgery. 72(5). 690–698. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026